| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9240447 | Nutrition | 2005 | 6 Pages |
Abstract
These results suggest that D-Fraction can decrease the effective dosage in tumor-bearing mice by increasing the proliferation, differentiation, and activation of immunocompetent cells and thus provide a potential clinical benefit for patients with cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Noriko Ph.D., Yukihito B.Pharm., Akihiro M.D., Ph.D., Akio M.D., Ph.D., Masahiko Ph.D., Norio M.D., Ph.D., Hiroaki Ph.D.,